APA (7th ed.) Citation

Bestion, E., Jilkova, Z. M., Mège, J., Novello, M., Kurma, K., Pour, S. T. A., . . . Brun, S. (2020). GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition. Therapeutic advances in chronic disease, 11, 2040622320942042. https://doi.org/10.1177/2040622320942042

Chicago Style (17th ed.) Citation

Bestion, Eloïne, et al. "GNS561 Acts as a Potent Anti-fibrotic and Pro-fibrolytic Agent in Liver Fibrosis Through TGF-β1 Inhibition." Therapeutic Advances in Chronic Disease 11 (2020): 2040622320942042. https://doi.org/10.1177/2040622320942042.

MLA (9th ed.) Citation

Bestion, Eloïne, et al. "GNS561 Acts as a Potent Anti-fibrotic and Pro-fibrolytic Agent in Liver Fibrosis Through TGF-β1 Inhibition." Therapeutic Advances in Chronic Disease, vol. 11, 2020, p. 2040622320942042, https://doi.org/10.1177/2040622320942042.